Grant - Immunovia

Grant - Immunovia

Investment Firm

Overview

Immunovia is a diagnostics company that focuses on the early detection of pancreatic cancer through blood-based testing.

Announced Date

Aug 05, 2024

Funding Type

Grant

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

National Institutes of Health

National Institutes of Health

National Institutes of Health is a grant and seed firm.

Participant Investors

1

Investor Name
Participant InvestorNational Institutes of Health

Round Details and Background

Immunovia raised $4500000 on 2024-08-05 in Grant

Immunovia is a diagnostics company that focuses on the early detection of pancreatic cancer through blood-based testing.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 01, 2015
Grant - Immunovia
1-4.6M
Jun 04, 2020
Post-IPO Equity - Immunovia
-43.5M
May 20, 2024
Post-IPO Debt - Immunovia
-1.4M
Aug 05, 2024
Grant - Immunovia
1-4.5M

Recent Activity

There is no recent news or activity for this profile.